Obesity Trial, Recruiting NCT06891534 Sponsor: Mayo Clinic Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06891534
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with a body mass index (BMI) in either the 20–25 range (considered a healthy weight) or the 30–37 range (considered obese)
  • People in the obese BMI range who also have a waist-to-hip ratio of 0.95 or higher (males) or 0.90 or higher (females), which is a measurement comparing waist and hip size
  • People who are largely inactive and do not do regular exercise (sedentary lifestyle)
  • Women who are not currently pregnant or breastfeeding
  • People who are able to sign a written consent form and follow the study instructions

Who may not be able to join:

  • People who have a history of taking medications that affect fat cells or fat metabolism
  • People who currently smoke
  • People who have insomnia (ongoing difficulty sleeping)
  • People who have sleep apnea (a condition where breathing repeatedly stops during sleep)
  • People who use sleep medications
  • People who work night shifts or rotating shifts
  • People who have extreme sleep/wake patterns — for example, very strong early-morning or very late-night preferences (confirm with trial site for exact definition)
  • People with an allergy to lidocaine (a type of local anaesthetic)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 507-255-1488

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 July 2021
Est. completion
1 December 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

rhythmicity of circadian clock mRNA in adipose tissue

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov